{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T08:35:30Z","timestamp":1721723730769},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,17]]},"DOI":"10.7759\/cureus.33879","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T15:52:18Z","timestamp":1673970738000},"source":"Crossref","is-referenced-by-count":1,"title":["Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder"],"prefix":"10.7759","author":[{"given":"Imran","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishman","family":"Tandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurnoor","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":".","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saikrishna","family":"Dodda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirgha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaganesh","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejaswini","family":"Maram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansh","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopeessh","family":"Vempati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udit","family":"Choubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2007.00308.x","article-title":"Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease","volume":"20","author":"Stubbs J","year":"2007","unstructured":"Stubbs J, Liu S, Quarles LD. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial. 2007, 20:302-8. 10.1111\/j.1525-139X.2007.00308.x","journal-title":"Semin Dial"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita T","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun. 2000, 277:494-8. 10.1006\/bbrc.2000.3696","journal-title":"Biochem Biophys Res Commun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa H","year":"2010","unstructured":"Hasegawa H, Nagano N, Urakawa I, et al.. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int. 2010, 78:975-80. 10.1038\/ki.2010.313","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson T","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, J\u00fcppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 2003, 64:2272-9. 10.1046\/j.1523-1755.2003.00328.x","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci DM","year":"2006","unstructured":"Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab. 2006, 91:3144-9. 10.1210\/jc.2006-0021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez OM","year":"2008","unstructured":"Guti\u00e9rrez OM, Mannstadt M, Isakova T, et al.. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008, 359:584-92. 10.1056\/NEJMoa0706130","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial","volume":"132","author":"Moe SM","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, et al.. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation. 2015, 132:27-39. 10.1161\/CIRCULATIONAHA.114.013876","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.177137","article-title":"Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India","volume":"27","author":"Anandh U","year":"2017","unstructured":"Anandh U, Mandavkar P, Das B, Rao S. Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India. Indian J Nephrol. 2017, 27:9-12. 10.4103\/0971-4065.177137","journal-title":"Indian J Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002622","article-title":"Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients","volume":"73","author":"Urena Torres P","year":"2008","unstructured":"Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Pri\u00e9 D. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int. 2008, 73:102-7. 10.1038\/sj.ki.5002622","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-018-0315-z","article-title":"Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients","volume":"23","author":"Zheng S","year":"2018","unstructured":"Zheng S, Chen Y, Zheng Y, Zhou Z, Li Z. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients. Eur J Med Res. 2018, 23:18. 10.1186\/s40001-018-0315-z","journal-title":"Eur J Med Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul M","year":"2006","unstructured":"Jadoul M, Albert JM, Akiba T, et al.. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2006, 70:1358-66. 10.1038\/sj.ki.5001754","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S171970","article-title":"Risk of hip fracture in patients on dialysis or kidney transplant: a meta-analysis of 14 cohort studies","volume":"14","author":"Tan J","year":"2018","unstructured":"Tan J, Li Y, Wu Z, Zhao J. Risk of hip fracture in patients on dialysis or kidney transplant: a meta-analysis of 14 cohort studies. Ther Clin Risk Manag. 2018, 14:1747-55. 10.2147\/TCRM.S171970","journal-title":"Ther Clin Risk Manag"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients","volume":"18","author":"Ure\u00f1a P","year":"2003","unstructured":"Ure\u00f1a P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant. 2003, 18:2325-31. 10.1093\/ndt\/gfg403","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese MD","year":"2006","unstructured":"Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis. 2006, 47:149-56. 10.1053\/j.ajkd.2005.09.024","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama JJ","year":"2005","unstructured":"Kazama JJ, Sato F, Omori K, et al.. Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int. 2005, 67:1120-5. 10.1111\/j.1523-1755.2005.00178.x","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi S","year":"2005","unstructured":"Nakanishi S, Kazama JJ, Nii-Kono T, et al.. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int. 2005, 67:1171-8. 10.1111\/j.1523-1755.2005.00184.x","journal-title":"Kidney Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2016.05.012","article-title":"Bone disease and serum fibroblast growth factor-23 levels in renal transplant recipients","volume":"48","author":"Coskun Y","year":"2016","unstructured":"Coskun Y, Paydas S, Balal M, et al.. Bone disease and serum fibroblast growth factor-23 levels in renal transplant recipients. Transplant Proc. 2016, 48:2040-5. 10.1016\/j.transproceed.2016.05.012","journal-title":"Transplant Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123670-correlation-of-fgf-23-with-biochemical-markers-and-bone-density-in-chronic-kidney-disease-bone-mineral-density-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:46Z","timestamp":1707508126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123670-correlation-of-fgf-23-with-biochemical-markers-and-bone-density-in-chronic-kidney-disease-bone-mineral-density-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.33879","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}